ZIM
CLDX icon

Zacks Investment Management’s Celldex Therapeutics CLDX Stock Holding History

Zacks Investment Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-733
Closed -$40K – 600
2017
Q1 		$40K Buy
+733
New +$38.2K ﹤0.01% 632
2016
Q4 		– Sell
-755
Closed -$46K – 651
2016
Q3 		$46K Sell
755
-3,824
-84% -$238K ﹤0.01% 639
2016
Q2 		$302K Buy
4,579
+101
+2% +$6.41K 0.01% 500
2016
Q1 		$254K Buy
4,478
+1,807
+68% +$203K 0.01% 523
2015
Q4 		$628K Buy
+2,671
New +$582K 0.02% 384

Other funds holding CLDX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
KE
KLP Enterprises Branford, Connecticut $1.97M AUM
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return